You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Eculizumab for treating atypical haemolytic uraemic syndrome

  • Highly specialised technologies guidance
  • Reference number: HST1
  • Published:  28 January 2015
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: final evaluation determination

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: final evaluation document

Atypical haemolytic uraemic syndrome (aHUS) - eculizumab: final evaluation documentAtypical haemolytic uraemic syndrome (aHUS) - eculizumab: final evaluation document
26 November 2014
(177.25 Kb 51 sec @ 28.8Kbps)
Adobe Acrobat reader required.

 Adobe Acrobat reader required.

Back to top